We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

67 hedge funds and large institutions have $88.5M invested in Neos Therapeutics, Inc in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 4

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

37% more funds holding

Funds holding: 49 → 67 (+18)

36% more capital invested

Capital invested by funds: $65M → $88.5M (+$23.5M)

20% more call options, than puts

Call options by funds: $403K | Put options by funds: $335K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
67
Holders Change
+18
Holders Change %
+36.73%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
21
Reduced
13
Closed
4
Calls
$403K
Puts
$335K
Net Calls
+$68K
Net Calls Change
+$68K

Top Buyers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
+$6.38M
2
SCM
Stonepine Capital Management
Oregon
+$4.27M
3
GTC
Ghost Tree Capital
New York
+$3.77M
4
EIM
Essex Investment Management
Massachusetts
+$1.45M
5
Russell Investments Group
Russell Investments Group
United Kingdom
+$1.28M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$4.83M
2
SBIA
Sheaff Brock Investment Advisors
Indiana
-$216K
3
BCM
Bridgeway Capital Management
Texas
-$188K
4
JP Morgan Chase
JP Morgan Chase
New York
-$99K
5
FPF
FNY Partners Fund
New York
-$87K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$396K +$47K +6,223 +13%
VKH
27
Virtu KCG Holdings
New York
$384K +$397K +52,619 New
CAM
28
Cormorant Asset Management
Massachusetts
$369K – – –
HAIM
29
Hunter Associates Investment Management
Pennsylvania
$365K – – –
OM
30
Opaleye Management
Massachusetts
$365K +$378K +50,000 New
TCIM
31
TIAA CREF Investment Management
New York
$342K +$16.4K +2,168 +5%
Charles Schwab
32
Charles Schwab
California
$320K +$168K +22,200 +103%
TA
33
Teachers Advisors
New York
$284K +$69.4K +9,190 +31%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$249K -$18.9K -2,500 -7%
SSA
35
Schonfeld Strategic Advisors
New York
$221K +$228K +30,231 New
HighTower Advisors
36
HighTower Advisors
Illinois
$204K +$211K +28,000 New
Morgan Stanley
37
Morgan Stanley
New York
$182K -$43K -5,693 -19%
AllianceBernstein
38
AllianceBernstein
Tennessee
$161K +$166K +22,000 New
Deutsche Bank
39
Deutsche Bank
Germany
$156K +$137K +18,168 +537%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$149K +$18.4K +2,441 +14%
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
$146K +$151K +20,000 New
MWM
42
Mission Wealth Management
California
$124K – – –
DTL
43
Dynamic Technology Lab
Singapore
$118K +$122K +16,195 New
OAC
44
OMERS Administration Corp
Ontario, Canada
$110K +$114K +15,100 New
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$102K +$106K +14,000 New
Group One Trading
46
Group One Trading
Illinois
$99K +$103K +13,608 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$88K – – –
AIG
48
American International Group
New York
$87K +$25.1K +3,323 +39%
TI
49
Trexquant Investment
Connecticut
$85K +$88.3K +11,700 New
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$76K -$8 -1 -0%
1
2
3

NEOS Hedge Fund Activity: Q2 2017 in Review

67 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q2 2017, worth a combined $88.5M — up 36% from $65M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NEOS positions and 4 closed out — a net gain of 18 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was J. Goldman & Co, opening a new position worth an estimated $6.38M. The largest seller was Deerfield Management, cutting an estimated $4.83M.

  • 67 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q2 2017, up from 49 in Q1 2017.
  • Funds reported $88.5M of Neos Therapeutics, Inc stock for Q2 2017, up 36% quarter-over-quarter.
  • 22 funds opened new Neos Therapeutics, Inc positions in Q2 2017 and 4 closed out, a net change of +18 holders.
  • The largest Neos Therapeutics, Inc buyer in Q2 2017 was J. Goldman & Co, an estimated $6.38M added.
  • The largest Neos Therapeutics, Inc seller in Q2 2017 was Deerfield Management, an estimated $4.83M sold.

Based on aggregated 13F filings for Q2 2017.